All stock lists
SpyGlass Pharma, Inc. (SGP)
NASDAQ: SGP · Real-Time Price · USD
Healthcare · Biotechnology
$29.68-$1.75 (-5.58%)
Insider Score
65/ 100
SGP Insider Score
Bullish1 qualifying trade · 1 insider · $32.43K bought in the last 90 days
SGP Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| SG&A Expense | $16.21 M | $11.03 M | $6.87 M | $5.92 M | $3.01 M | — |
| R&D Expense | $10.03 M | $10.94 M | $8.54 M | $7.71 M | $8.09 M | — |
| Operating Expenses | $26.25 M | $21.97 M | $15.41 M | $13.63 M | $11.10 M | — |
| Operating Income | -$26.25 M | -$21.97 M | -$15.41 M | -$13.63 M | -$11.10 M | — |
| Pretax Income | -$24.25 M | -$19.86 M | -$13.82 M | -$12.56 M | -$9.82 M | — |
| Tax Provision | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Net Income | -$24.25 M | -$19.86 M | -$13.82 M | -$12.56 M | -$9.82 M | — |
| EPS (Basic) | -$0.73 | -$0.59 | -$0.69 | — | — | -$0.27 |
| EPS (Diluted) | -$0.73 | -$0.59 | -$0.69 | — | — | -$0.27 |
| Shares Outstanding | 33.45 M | 33.44 M | 19.93 M | — | — | 31.91 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
